Headlands Technologies LLC Grows Stake in Amedisys, Inc. (NASDAQ:AMED)

Headlands Technologies LLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED) by 106.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,072 shares of the health services provider’s stock after purchasing an additional 2,619 shares during the quarter. Headlands Technologies LLC’s holdings in Amedisys were worth $460,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Norges Bank purchased a new position in Amedisys in the fourth quarter worth about $83,061,000. Wealthfront Advisers LLC purchased a new position in Amedisys in the 4th quarter worth approximately $72,970,000. Pacer Advisors Inc. lifted its position in Amedisys by 11,621.9% in the 4th quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock valued at $50,679,000 after acquiring an additional 553,435 shares in the last quarter. Birnam Oak Advisors LP purchased a new stake in Amedisys during the 4th quarter valued at $15,832,000. Finally, Calamos Advisors LLC increased its holdings in shares of Amedisys by 22.7% in the 4th quarter. Calamos Advisors LLC now owns 487,444 shares of the health services provider’s stock worth $44,255,000 after purchasing an additional 90,097 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Analysts Set New Price Targets

Separately, Stephens reaffirmed an “equal weight” rating and set a $101.00 price objective on shares of Amedisys in a research report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $101.00.

Amedisys Trading Up 0.0 %

Shares of AMED stock opened at $92.99 on Friday. The stock has a market capitalization of $3.05 billion, a P/E ratio of 36.90, a P/E/G ratio of 1.78 and a beta of 0.76. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm’s 50 day moving average is $92.33 and its 200 day moving average is $92.35. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.09). The firm had revenue of $598.05 million during the quarter, compared to analysts’ expectations of $602.38 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Research analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.